Q3 Report Nov. 10 after close | RGLS Message Board Posts


Regulus Therapeutics Inc.

  RGLS website

RGLS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  764 of 846  at  11/10/2021 4:44:17 PM  by

Steve_382


 In response to msg 763 by  arthurs1
view thread

Re: Q3 Report Nov. 10 after close

OK, the report is out. Will have to listen to the CC for additional comments, but my take away from the PR:
 
  • $35M in cash, or about enough for a year.
  • RGLS8429 appears to be about as effective as RGLS4326 (but not more effective?) and without some of the problems 
  • Possible start of a trial in Q2 of 2022, so maybe 6 months from now
  • Top line data in early 2023 or at least 15 months from now
 
 My take is they will likely need more cash before the readout. I don't know, but I still don't see any hurry to jump back in right now.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 1  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
765 Re: Q3 Report Nov. 10 after close Steve_382 2 11/10/2021 5:35:31 PM




Financial Market Data provided by
.
Loading...